Vitamin D levels and patient outcome in chronic kidney disease
Pietro Ravani(University of Calgary), Carmine Zoccali(Università Campus Bio-Medico), Patrizia Pizzini, Sebastiano Cutrupi(National Research Council), Paola Pecchini(Istituti Ospitalieri di Cremona), Giovanni Tripepi(Metabolism and Renal Physiology), Fabio Malberti(Istituti Ospitalieri di Cremona), Francesca Mallamaci(Metabolism and Renal Physiology)
Cited by 436
Related Papers
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
|American Journal of Nephrology|2017|2.2k
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study
|The Lancet|2001|1.1k
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
|The Lancet|1999|909
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Kidney International|2019|886
An introduction to inverse probability of treatment weighting in observational research
|Clinical Kidney Journal|2021|877